Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Anthony Brennan Insider Profile
4 Followers
Paul Anthony Brennan, Former at InMed Pharmaceuticals, holds 1.10M shares in InMed Pharmaceuticals (Ticker: INM), holds 619.35K shares in NervGen Pharma (Ticker: NGENF), holds 7.00K shares in Arbutus Biopharma (Ticker: ABUS). Most recently, Paul Anthony Brennan ― shares of InMed Pharmaceuticals on ― for an estimated value of ―.
Paul Anthony Brennan InMed Pharmaceuticals (INM)Former
InMed Pharmaceuticals (INM)
Former
Ranked #58,401 out of 99,218 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-5.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Paul Anthony Brennan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul Anthony Brennan
Paul Anthony Brennan's Trading History
InMed Pharmaceuticals
―
Former
―
$258.50K
NervGen Pharma
May 06, 2022
President & Chief Executive Officer
Uninformative Sell
80.00K
$1.17M
Arbutus Biopharma
―
Senior Vice-President Business Development
―
$26.25K
Eupraxia Pharmaceuticals
Aug 21, 2023
Chief Business Officer
Informative Buy
35.00K
C$119.68K
List of latest transactions for each holding click on a transaction to see Paul Anthony Brennan's performance on stock
You May Also Like
Paul Anthony Brennan insider profile FAQ
What is the percentage of profitable transactions made by Paul Anthony Brennan?
The percentage of profitable transactions made by Paul Anthony Brennan is 25%.
What is the average return per transaction made by Paul Anthony Brennan?
The average return per transaction made by Paul Anthony Brennan is -5.70%.
What stocks does Paul Anthony Brennan hold?
Paul Anthony Brennan holds: INM, NGENF, ABUS, TSE:EPRX stocks.
What was Paul Anthony Brennan’s latest transaction?
Paul Anthony Brennan latest transaction was an Uninformative Buy of ―.
What was Paul Anthony Brennan's most profitable transaction?
Paul Anthony Brennan’s most profitable transaction was an Informative Buy of NGENF stock on May 15, 2021. The return on the trade was 44.80%.
What is Paul Anthony Brennan's role in InMed Pharmaceuticals?
Paul Anthony Brennan's role in InMed Pharmaceuticals is Former.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.